Atherosclerosis Cardiovascular Disease

Explore clinical trials studying Atherosclerosis Cardiovascular Disease. Study availability and eligibility vary by location and protocol.

17 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Atherosclerosis Cardiovascular Disease trial results

Not yet recruiting

Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling

NCT07641257

Conditions: Acute Coronary Syndrome, Acute Coronary Syndromes (ACS), Arterial Occlusive Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health

NCT07462871

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +12 more
Locations: Tom Reilly Building, Liverpool John Moores University Liverpool, United Kingdom

View Trial Details

Not yet recruiting

Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis

NCT07422051

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +3 more
Locations: Instituto de la Grasa-CSIC Seville, Spain

View Trial Details

Not yet recruiting

Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial

NCT06856772

Conditions: Atherosclerosis Cardiovascular Disease, Cardiovascular Diseases, Cardiovascular Diseases (CVD), +1 more
Locations: Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hellerup, Denmark

View Trial Details

Not yet recruiting

Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.

NCT06720662

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +3 more
Locations: Not specified

View Trial Details

Not yet recruiting

Variability in Human Fatty Acids Profiles Based on Blood Fractions and Metabolic Conditions

NCT06731400

Conditions: Atherosclerosis Cardiovascular Disease
Locations: Not specified

View Trial Details

Completed

Lipoprotein (a) and Vascular Regenerative Cell Content

NCT06626659

Conditions: Atherosclerosis Cardiovascular Disease, Cardiovascular Diseases, Dyslipidemia, +8 more
Locations: North York Diagnostic and Cardiac Centre North York, Ontario, Canada

Diagnostic Assessment Centre Scarborough Village, Ontario, Canada

View Trial Details

Atherosclerosis Cardiovascular Disease

Atherosclerosis Cardiovascular Disease trial results

Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling

Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health

Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis

Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial

Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.

Variability in Human Fatty Acids Profiles Based on Blood Fractions and Metabolic Conditions

Lipoprotein (a) and Vascular Regenerative Cell Content

Related conditions